Skip to main content

First North American H5N1 Death

A person in Canada has died of the first confirmed human case of H5N1 avian flu in North America.

Written byAbby Olena, PhD
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00

H5N1 virionCDC, CYNTHIA GOLDSMITH, JACKIE KATZA patient hospitalized in Alberta, Canada, died January 3 from a confirmed case of the H5N1 avian influenza virus, Canadian Health Minister Rona Ambrose announced this week (January 8). According to CTV News, the female patient, whose name has not been released, returned from Beijing, China, to Edmonton via Vancouver on December 27 and reported feeling ill during the trip. This case of H5N1 was the first in North America, according to a map created by the US Centers for Disease Control and Prevention, detailing the number, location, and outcome of the other 647 cases reported worldwide since 2003.

On its website, the CDC explains that H5N1 occurs mainly in birds, among which it is extremely contagious and can be deadly. H5N1 has also been found in a domestic dog, in pigs, in domestic cats, and in humans. The virus is generally thought to be transmitted by contact with affected birds, and to not be spread easily between people. “The risk of getting H5N1 is very low,” Ambrose told reporters in Ottawa, according to The New York Times.

“This case of avian flu in Alberta is very rare and isolated,” Alberta health minister Fred Horne said at a press conference included in the CTV story. “Other Albertans are not at risk.” According to CTV, public health officials said that none of the patient’s close ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • abby olena

    As a freelancer for The Scientist, Abby reports on new developments in life science for the website. She has a PhD from Vanderbilt University and got her start in science journalism as the Chicago Tribune’s AAAS Mass Media Fellow in 2013. Following a stint as an intern for The Scientist, Abby was a postdoc in science communication at Duke University, where she developed and taught courses to help scientists share their research. In addition to her work as a science journalist, she leads science writing and communication workshops and co-produces a conversational podcast. She is based in Alabama.  

    View Full Profile

Related Topics

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo